CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 25  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0906
LYS 10.0484
GLU 20.0299
LEU 30.0239
ARG 40.0093
CYS 50.0361
GLN 60.0304
CYS 70.0261
ILE 80.0039
LYS 90.0038
THR 100.0020
TYR 110.0076
SER 120.0047
LYS 130.0070
PRO 140.0071
PHE 150.0075
HIS 160.0127
PRO 170.0115
LYS 180.0235
PHE 190.0172
ILE 200.0163
LYS 210.0182
GLU 220.0124
LEU 230.0140
ARG 240.0061
VAL 250.0109
ILE 260.0252
GLU 270.0333
SER 280.0261
GLY 290.0239
PRO 300.0497
HIS 310.0222
CYS 320.0358
ALA 330.0496
ASN 340.0354
THR 350.0223
GLU 360.0188
ILE 370.0079
ILE 380.0056
VAL 390.0120
LYS 400.0161
LEU 410.0155
SER 420.0228
ASP 430.0265
GLY 440.0288
ARG 450.0270
GLU 460.0193
LEU 470.0137
CYS 480.0082
LEU 490.0074
ASP 500.0018
PRO 510.0058
LYS 520.0143
GLU 530.0186
ASN 540.0349
TRP 550.0158
VAL 560.0123
GLN 570.0241
ARG 580.0168
VAL 590.0124
VAL 600.0180
GLU 610.0167
LYS 620.0130
PHE 630.0148
LEU 640.0145
LYS 650.0071
ARG 660.0062
ALA 670.0157
GLU 680.0454
ASN 690.0906

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.